Lewy Body Dementia Association Appoints Anthony Schueth to Board of Directors

Association supports an estimated 1.4 million individuals and their families in the United States affected by Lewy body dementias ATLANTA, 10/15/2019 — The Lewy Body Dementia Association (LBDA) is proud […]
Read More

ACADIA Pharmaceuticals Submits Supplemental New Drug Application to U.S. FDA

ACADIA Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential new indication for NUPLAZID® (pimavanserin) for the treatment […]
Read More

Press Releases

LBDA Announces Appointment of Tony Schueth to Board of Directors LBDA Responds to Ted Turner’s LBD Diagnosis LBDA Announces Appointment of Emily Pualwan to Board of Directors
Read More